CN109321639A - κ-casein genotype method is detected based on KASP technology - Google Patents

κ-casein genotype method is detected based on KASP technology Download PDF

Info

Publication number
CN109321639A
CN109321639A CN201811181116.4A CN201811181116A CN109321639A CN 109321639 A CN109321639 A CN 109321639A CN 201811181116 A CN201811181116 A CN 201811181116A CN 109321639 A CN109321639 A CN 109321639A
Authority
CN
China
Prior art keywords
site
primer
dna
blood
upstream
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811181116.4A
Other languages
Chinese (zh)
Inventor
赵凤
刘林
杨宇泽
路永强
常卓
赵春颖
吕小青
赵凤茹
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beijing General Station Of Animal Husbandry
BEIJING DAIRY CATTLE CENTER
Original Assignee
Beijing General Station Of Animal Husbandry
BEIJING DAIRY CATTLE CENTER
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing General Station Of Animal Husbandry, BEIJING DAIRY CATTLE CENTER filed Critical Beijing General Station Of Animal Husbandry
Priority to CN201811181116.4A priority Critical patent/CN109321639A/en
Publication of CN109321639A publication Critical patent/CN109321639A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/6858Allele-specific amplification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

κ-casein genotype method is detected based on KASP technology the present invention relates to a kind of, includes the following steps: to prepare DNA sample;Prepare PCR amplification system;Carry out PCR amplification;Mix primer in PCR amplification system includes three kinds of KASP primers: upstream mutated gene primer, the unmutated gene primer in upstream and downstream primer, and, in the unmutated gene primer of upstream mutated gene primer and upstream, one design has HEX fluorescence labels sequence, and another design has FAM fluorescence labels sequence;According to the fluorescence intensity of DNA sample after PCR amplification, Genotyping is carried out.The present invention realizes comprehensive screening to tri- kinds of common variants of CSN3 in milk cow, the resource in the fields such as genetic test and technical advantage can be made full use of to cultivate high-quality kind of ox, excavate milk cow characteristic germ plasm resource, suitable milk cow is selected for pasture, improve protein ratio, the technical bottleneck that related fields is solved from provenance is of great significance to the sound development of milk cow breeding industry.

Description

κ-casein genotype method is detected based on KASP technology
Technical field
The present invention relates to molecular biology and Biotechnology in Genetic Breeding fields, and in particular to one kind detects κ-based on KASP technology The method of casein genotype.
Background technique
κ-casein (kappa-casein, k-CN) be cow's milk glandular secretion a kind of phosphoprotein containing a small amount of phosphate it One.Content of the κ-casein in cow's milk accounts for about the 12% of total casein, is the natural substrate of renin.And κ-CN is most heavy One of casein wanted, it not only serve in terms of the stability of casein micelles it is vital, but also to Lactation of Dairy Cow Performance, milk composition composition and cheese quality have a degree of influence.
Coding κ-casein gene is named as CSN gene, it has now been found that, there are many CSN bases of type in ox Cause.The κ of bovine animals-casein gene CSN3 synthesizes protein and the stabilization of micellar casein plays an important role, in milk It is of great significance in junket production, is the natural substrate of renin.There are 15 kinds of variants in ox κ-CN, it is non-synonymous by nucleotide Replacement causes.Most common three genetic variants are A, B and E, they have difference, A in 136,148,155,168 amino acids Four sites be respectively Thr, Asp, Ser, Ala, and B is Ile, Ala, Ser, Ala, E Thr, Asp, Gly, Ala.Accordingly Nucleotide replacement is respectively ACC → ATC, GAT → GCT, AGC → GGC, GCA → GCG.
Many studies have shown that κ-CN gene may will affect the output of milk, butterfat production, Milk protein yield, the butterfat percnetage (F) of cow With protein ratio (P), and the coagulating property and cheese yield of cow's milk are had a significant impact.Studies have shown that κ-CN is to butterfat percnetage It has a significant impact.The milk butterfat percnetage with higher of the variant of-CNB containing κ, faster curdled milk speed and higher grumeleuse are hard Degree.κ-CN protein genetic polymorphisms have a significant impact economic characters such as cheese making characteristic etc..Especially newborn rheology Characteristic is learned, κ-CNB allele shows positive influence to casein number.Casein content is milk as cheesemaking One important indicator of raw material.Therefore, screening is carried out to which the quality for improving dairy product is necessary to κ-CN gene.
With the development of molecular biotechnology, DNA analysis brings new vitality to cow's milk protein polymorphism research.Successively Establish DNA level analysis lactoprotein genetic variant method, main method have PCR-SSCP, PCR-RFLP, direct Sequencing, Allele specific pcr and genetic chip etc., due to first two method is easier to operate and to equipment requirement it is not high, application is more general Time, rear three kinds of methods detection is accurate, but higher cost, is not suitable for large sample detection.
The country is more suitable for there has been no being associated with κ-casein gene polymorphism with cow's milk processing characteristics to filter out at present The report of cheese production or the higher ox of protein yield only.
Summary of the invention
There is solution the shortcomings of the prior art, the present invention provides one kind to detect κ-casein gene based on KASP technology The method of type, includes the following steps:
Step S1: preparation DNA sample;
Step S2: PCR amplification system is prepared, wherein the interior DNA sample including 50% volume fraction of the amplification system, The mix primer of 1.2-1.6% volume fraction and the KASP mixed liquor of surplus;
Step S3: PCR amplification is carried out;
Wherein, the mix primer added in step S2 include three kinds of KASP primers, respectively upstream mutated gene primer, on Unmutated gene primer and downstream primer are swum, also, in the unmutated gene primer of upstream mutated gene primer and upstream, one Design has HEX fluorescence labels sequence, and another design has FAM fluorescence labels sequence, by according to DNA sample after PCR amplification Fluorescence intensity, carry out Genotyping.
Wherein, in the step S2, added mix primer includes four groups, is used to detect mutational site everywhere respectively Base type, also, be directed to different mutational sites, the primer of design is as follows:
(1) when base type on the site CSN3_136 to be detected, primer includes: the unmutated gene primer in upstream GAGCCTACAAGTACACCTACCAC, upstream mutated gene primer GAGCCTACAAGTACACCTACCAT and downstream primer GTAGCTACAGTGCTCTCTACTGCTT;
(2) when base type on the site CSN3_148 to be detected, primer includes: the unmutated gene primer in upstream AGAGCACTGTAGCTACTCTAGAAGA, upstream mutated gene primer AGCACTGTAGCTACTCTAGAAGC and downstream primer GTTGATCTCAGGTGGGCTCTCAATA;
(3) when base type on the site CSN3_155 to be detected, primer includes: the unmutated gene primer in upstream GTGTTGATCTCAGGTGGGCT, upstream mutated gene primer GTGTTGATCTCAGGTGGGCC and downstream primer GAGCACTGTAGCTACTCTAGAAGCTT;
(4) when base type on the site CSN3_168 to be detected, primer includes: upstream mutated gene primer TGATGTCTCCTTAGAGTATTTAGACC, the unmutated gene primer CTTTGATGTCTCCTTAGAGTATTTAGACT in upstream with And downstream primer TGAGATCAACACAGTCCAAGTTACTTCAA.
Wherein, when base type on (1) site CSN3_136 to be detected, if corresponding FAM only occur glimmering by DNA after amplification Luminous intensity, then two chains are unmutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two on the site Chain is mutated;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one is not dashed forward Become;
(2) when base type on the site CSN3_148 to be detected, if corresponding FAM fluorescence only occur strong by DNA after amplification Degree, then two chains are unmutated on the site;If only there are corresponding HEX fluorescence intensity, two chains on the site in DNA after amplification It is mutated;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated;
(3) when base type on the site CSN3_155 to be detected, if corresponding FAM fluorescence only occur strong by DNA after amplification Degree, then two chains are unmutated on the site;If only there are corresponding HEX fluorescence intensity, two chains on the site in DNA after amplification It is mutated;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated;
(4) when base type on the site CSN3_168 to be detected, if corresponding FAM fluorescence only occur strong by DNA after amplification Degree, then two chains are mutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are equal on the site It is unmutated;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated.
Wherein, in the step S3, the step of PCR amplification, includes:
Step S31: when temperature is 90-95 degrees Celsius hot activation 14-16 minutes, 90-95 degrees Celsius of time variation 18-22 Second, it anneals at 65-50 degrees Celsius and extends 55-65 second, carry out 10 and recycle;
Step S32: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extends 55-65 Second, carry out 24-28 circulation;
Step S33: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extends 55-65 Second, carry out 3 circulations.
Wherein, in the step S3, the step of PCR amplification, includes:
Step S31: temperature be 94 degrees Celsius when hot activation 15 minutes, 94 degrees Celsius time variation 20 seconds, 61-55 degrees Celsius When anneal and extend 60 seconds, carry out 10 circulation;
Step S32: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 55 degrees Celsius and extend 60 seconds, carries out 26 Circulation;
Step S33: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 57 degrees Celsius and extend 60 seconds, carries out 3 and follows Ring.
Wherein, in the step S1, the extracting method of DNA sample includes:
Step S11: blood-material is pre-processed;
Step S12: blood-material is successively digested by Porteinase K solution and buffer GB, keeps solution system clear Clearly;
Step S13: addition buffer solution B D mixes well;
Step S14: solution is placed in adsorption column CG2, and waste liquid is abandoned in room temperature centrifugation;
Step S15: being added buffer GDB, and waste liquid is abandoned in room temperature centrifugation;
Step S16: being added buffer PWB, and room temperature centrifugation is abandoned waste liquid, is repeated at least once more;
Step S17: the adsorption column CG2 finally obtained is placed in collecting pipe, and waste liquid is abandoned in room temperature centrifugation;
Step S18: elution adsorption column CG2 it is quantitative to carry out DNA;
Step S19: the integrality of DNA sample is detected by agarose gel electrophoresis.
Wherein, in the step S11, carrying out pretreated step to blood-material includes: that 1- is added into blood sample The cell pyrolysis liquid CL of 2.5 times of volumes, is handled using Syrup-homogenizing instrument, is centrifuged later, and supernatant is abandoned, and leaves nucleus precipitating, Buffer GS is added into nucleus precipitating, oscillation is mixed to thorough;
Wherein, if without blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:1, if there is blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:2.
Wherein, in the step S12, if blood-material is without clot, the body of Porteinase K solution and blood-material Ratio is accumulated as 1:50, the volume ratio of buffer GB and blood-material is 1:5;If blood-material has clot, Porteinase K is molten The volume ratio of liquid and blood-material is 1:25, and the volume ratio of buffer GB and blood-material is 2:5.
Wherein, in the step S13, the volume of added buffer GB in added buffer solution B D and step S12 Than between 1:1-2:1;
In the step S15, the volume ratio of added buffer GB is situated between in added buffer GDB and step S12 In 2:1-3:1;
In the step S16, the volume ratio of added buffer GB is situated between in added buffer PWB and step S12 In 2:1-4:1;
Also, the step S14, into step S16, for the speed of centrifugation between 10000-14000rpm, centrifugation time is equal Between 20-40 seconds;
In the step S17, the speed of centrifugation is between 10000-14000rpm, and centrifugation time is between 1.5-2.5 points.
Wherein, in the step S18, the elution process of adsorption column CG2 includes:
Step S18a: elution buffer TB, the volume that elution buffer TB is added, with step is vacantly added dropwise to adsorption column CG2 The volume ratio of added buffer GB is between 1:4-1:1 in rapid S12;
Step S18b: being placed at room temperature for two minutes, and waste liquid is abandoned in room temperature centrifugation, centrifugal speed between 10000-14000rpm, from The heart time is between 1.5-2.5 points.
It is provided by the invention that κ-casein genotype method is detected based on KASP technology, it realizes to CSN3 in milk cow Comprehensive screening of (κ-CN gene) three kinds of common variants can make full use of the resource in the fields such as genetic test and technical advantage to train High-quality kind of ox is educated, milk cow characteristic germ plasm resource is excavated, suitable milk cow is selected for pasture, improves protein ratio, solved from provenance The technical bottleneck of related fields is of great significance to the sound development of milk cow breeding industry.
Detailed description of the invention
Fig. 1: of the invention that one genotyping result figure of κ-casein genotype method is detected based on KASP technology.
Specific embodiment
In order to have further understanding to technical solution of the present invention and beneficial effect, it is described in detail with reference to the accompanying drawing Technical solution of the present invention and its beneficial effect of generation.
The present invention is directed to be screened by Genotyping to common variants in three in CSN3 (κ-CN gene) comprehensively, To provide reference for scientific seed selection and selective pairing.
One, the preparation of DNA sample
In the present invention, using the blood of milk cow as extraction, the material of preparation DNA sample.
1, blood-material pre-processes:
(1) it if blood takes 1000ul blood to be tested without blood clot, need to be handled with cell pyrolysis liquid CL, specifically Step: being added the cell pyrolysis liquid CL of 1-2.5 times of volume, be mixed by inversion in sample, 10,000rpm (11,500g) are centrifuged 1min, Supernatant is sucked, nucleus precipitating (if cracking is not thorough, it is primary to repeat above step) is left, to the cell being collected by centrifugation In core precipitating plus 200ul buffer GS, oscillation are mixed to thorough.
(2) if blood has blood clot, 500ul blood clot is taken to be tested, need to be handled with cell pyrolysis liquid CL, specifically Step: in sample be added 1-2.5 times of volume cell pyrolysis liquid CL, handled using Syrup-homogenizing instrument, carried out after being disposed from The heart 10,000rpm (11,500g), 1min, sucks supernatant, leaves nucleus precipitating and (if cracking is not thorough, repeats the above step It is rapid primary), into the nucleus precipitating being collected by centrifugation plus 200ul buffer GS, oscillation are mixed to thorough.
If blood is to freeze state, it need to thaw in 37 DEG C of water-baths, forbid thaw at RT.
It if it is new blood and has been layered, heparin tube gentle inversion need to have been mixed, then carried out taking blood step.
Accordingly, with respect to common kit, the present invention as desired by the additive amount of blood (no blood clot), by 200ul is promoted to 1000ul (blood is without grumeleuse) or 500ul (blood has blood clot) and carries out pre-treatment, makes the base finally extracted Because group DNA concentration is in 100ng/ul or more, detection accuracy is increased.
2, into the blood sample pre-processed, 20ul Porteinase K is added, mixes well.
3,200ul buffer GB is added, is sufficiently mixed by inversion, 56 DEG C of water-bath 10min are mixed by inversion for several times therebetween, make molten Liquid, which sufficiently digests, becomes limpid.
If solution does not become limpid thoroughly, need to extend pyrolysis time until solution is limpid.
4,350ul buffer solution B D is added after being placed at room temperature for 2-5min, is sufficiently mixed by inversion.This step is likely to occur cotton-shaped heavy It forms sediment, but without dispelling.
5, upper step acquired solution and flocculent deposit are added in adsorption column CG2 (adsorption column is put into collecting pipe), room temperature from The heart, 12,000rpm (13,400g), 30sec abandon waste liquid.
6,500ul buffer GDB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
7,600ul rinsing liquid PWB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
8,600ul rinsing liquid PWB, room temperature centrifugation, 12,000rpm (13,400g), 30sec, abandoning waste liquid is added.
9, CG2 adsorption column is put back in collecting pipe, room temperature centrifugation, 12,000rpm (13,400g), 2min abandons waste liquid.
10, adsorption column CG2 pipe lid is opened, is placed at room temperature for several minutes, thoroughly to dry remaining rinsing liquid in adsorbent material.
11, adsorption column CG2 is put into a clean 1.5ml EP pipe, is washed to the hanging 50-200ul that is added dropwise in adsorbed film center De- buffer TB is placed at room temperature for 2min, room temperature centrifugation, 12,000rpm (13,400g), 2min.
For the yield for increasing genomic DNA, obtained solution can be rejoined in adsorption column CG2, be placed at room temperature for 2min, Room temperature centrifugation, 12,000rpm (13,400g), 2min.
12, it is quantitative to carry out gDNA, if at once not quantitative, sample is frozen.
13, agarose gel electrophoresis detects gDNA integrality.
Two, the design of primer
κ of the invention-casein genotype classifying method is absorbed in and detects tri- kinds of genotype of A, B and E therein, and three kinds Genotype is related to six kinds of different milk cow genomes, also, is related to the catastrophe point everywhere on CSN3.
Table 1 is four group primer sequences and each primer amplification band institute of the present invention for the mutation point design of different location Corresponding base type, table 2 are in the present invention, and six kinds of different milk cow genomes are corresponding on four different mutational sites Base type.
Table 1: primer of the present invention for different mutation point designs
Table 2: corresponding base type on the different mutational sites that the present invention is measured
Genotype CSN3_136 CSN3_148 CSN3_155 CSN3_168
AA C A A A
AB CT AC A GA
AE C A AG A
BB T C A G
BE CT AC AG GA
EE C A G A
Three, PCR amplification
In the present invention, the PCR system for amplification is 5 μ L, including 2.5 μ L DNA, 2.5 Μ l KASP Master Mix (LGC Genomics, Hoddeston, UK, KASP mixed liquor), 0.07 μ L mix primer.To avoid the erroneous judgement to test result, Blank control, DNA profiling ddH are set2O (distilled water) is replaced.The hot activation when temperature is 94 DEG C of the condition of PCR amplification It anneals when 15min, 94 DEG C of time variation 20s, 61-55 DEG C and extends 60s, carries out 10 circulations;When 94 DEG C of time variation 20s, 55 DEG C Annealing and extension 60s, 26 circulations are carried out;It anneals when 94 DEG C of time variation 20s, 57 DEG C and extends 60s, carries out 3 circulations.
Four, genotyping result
As described above, in table 1 of the invention, every group of PCR amplification primer includes three kinds of amplified bands: upstream mutated gene draws Object, the unmutated gene primer in upstream and downstream primer, also, the unmutated gene primer of upstream mutated gene primer and upstream In, a design has HEX fluorescence labels sequence, and another design has FAM fluorescence labels sequence;After PCR amplification, different DNA Different fluorescence intensities can be presented in sample.By taking CSN3_136 catastrophe point as an example, incorporated by reference to shown in Fig. 1, it is assumed that certain milk cow is here Unmutated (genotype of milk cow may be AA, AE or EE at this time), then the base type at the position is C, can only be gone out after DNA cloning The existing corresponding amplified band of the unmutated gene primer in upstream, that is, FAM, which is presented, in the DNA finally expanded corresponds to fluorescence intensity, i.e. Fig. 1 The color (red) in the lower right corner;Assuming that certain milk cow have here the mutation of chain (at this time the genotype of milk cow may for AB or BE), then the base type of a chain is C at the position, and another is T, can occur upstream mutated gene primer simultaneously after DNA cloning And the corresponding amplified band of the unmutated gene primer in upstream, that is, HEX, which is presented, in the DNA finally expanded corresponds to fluorescence intensity and FAM pairs Answer the secondary colour of fluorescence intensity, i.e. iridescent among Fig. 1;Assuming that two chains are mutated (milk cow at this time to certain milk cow here Genotype is BB), then base type is T at the position, only will appear the corresponding amplification of upstream mutated gene primer after DNA cloning Band, that is, the color that HEX corresponds to fluorescence intensity, the i.e. color (navy blue) in the upper left corner Fig. 1 is presented in the DNA finally expanded.
In conjunction with the amplification of other catastrophe points, can comprehensive descision milk cow genotype.
It is so-called " Proteinase K solution " in the present invention, refer to Proteinase K Solution;So-called cell pyrolysis liquid CL, Buffer GDB, buffer GB, buffer GS, buffer PWB, buffer solution B D, adsorption column CG2 and eluent TB, are selected from day Root kit self-contained reagent.
It is provided by the invention that κ-casein genotype method is detected based on KASP technology, it realizes to CSN3 in milk cow Comprehensive screening of (κ-CN gene) three kinds of common variants can make full use of the resource in the fields such as genetic test and technical advantage to train High-quality kind of ox is educated, milk cow characteristic germ plasm resource is excavated, suitable milk cow is selected for pasture, improves protein ratio, solved from provenance The technical bottleneck of related fields is of great significance to the sound development of milk cow breeding industry.
Although the present invention is illustrated using above-mentioned preferred embodiment, the protection model that however, it is not to limit the invention It encloses, anyone skilled in the art are not departing within the spirit and scope of the present invention, and opposite above-described embodiment carries out various changes It is dynamic still to belong to the range that the present invention is protected with modification, therefore protection scope of the present invention subjects to the definition of the claims.

Claims (10)

1. a kind of detect κ-casein genotype method based on KASP technology, which comprises the steps of:
Step S1: preparation DNA sample;
Step S2: PCR amplification system is prepared, wherein DNA sample, 1.2- in the amplification system including 50% volume fraction The mix primer of 1.6% volume fraction and the KASP mixed liquor of surplus;
Step S3: PCR amplification is carried out;
Wherein, the mix primer added in step S2 includes three kinds of KASP primers, respectively upstream mutated gene primer, upstream not Mutated gene primer and downstream primer, also, in the unmutated gene primer of upstream mutated gene primer and upstream in, one sets In respect of HEX fluorescence labels sequence, another design has FAM fluorescence labels sequence, by according to DNA sample after PCR amplification Fluorescence intensity carries out Genotyping.
2. detecting κ-casein genotype method based on KASP technology as described in claim 1, which is characterized in that the step In rapid S2, added mix primer includes four groups, is used to detect the base type in mutational site everywhere, also, needle respectively To different mutational sites, the primer of design is as follows:
(1) when base type on the site CSN3_136 to be detected, primer includes: the unmutated gene primer in upstream GAGCCTACAAGTACACCTACCAC, upstream mutated gene primer GAGCCTACAAGTACACCTACCAT and downstream primer GTAGCTACAGTGCTCTCTACTGCTT;
(2) when base type on the site CSN3_148 to be detected, primer includes: the unmutated gene primer in upstream AGAGCACTGTAGCTACTCTAGAAGA, upstream mutated gene primer AGCACTGTAGCTACTCTAGAAGC and downstream primer GTTGATCTCAGGTGGGCTCTCAATA;
(3) when base type on the site CSN3_155 to be detected, primer includes: the unmutated gene primer in upstream GTGTTGATCTCAGGTGGGCT, upstream mutated gene primer GTGTTGATCTCAGGTGGGCC and downstream primer GAGCACTGTAGCTACTCTAGAAGCTT;
(4) when base type on the site CSN3_168 to be detected, primer includes: upstream mutated gene primer TGATGTCTCCTTAGAGTATTTAGACC, the unmutated gene primer CTTTGATGTCTCCTTAGAGTATTTAGACT in upstream with And downstream primer TGAGATCAACACAGTCCAAGTTACTTCAA.
3. detecting κ-casein genotype method based on KASP technology as claimed in claim 2, which is characterized in that
(1) when base type on the site CSN3_136 to be detected, if only there is corresponding FAM fluorescence intensity in DNA after amplification, Two chains are unmutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are prominent on the site Become;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated;
(2) when base type on the site CSN3_148 to be detected, if only there is corresponding FAM fluorescence intensity in DNA after amplification, Two chains are unmutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are prominent on the site Become;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated;
(3) when base type on the site CSN3_155 to be detected, if only there is corresponding FAM fluorescence intensity in DNA after amplification, Two chains are unmutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are prominent on the site Become;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated;
(4) when base type on the site CSN3_168 to be detected, if only there is corresponding FAM fluorescence intensity in DNA after amplification, Two chains are mutated on the site;If corresponding HEX fluorescence intensity only occurs in DNA after amplification, two chains are not dashed forward on the site Become;If two kinds of mixing fluorescence intensities occurs in DNA after amplification, two one, chain mutation on the site, one unmutated.
4. detecting κ-casein genotype method based on KASP technology as described in claim 1, which is characterized in that the step In rapid S3, the step of PCR amplification, includes:
Step S31: temperature be 90-95 degrees Celsius when hot activation 14-16 minutes, 90-95 degrees Celsius time variation 18-22 seconds, 65- It anneals and extends 55-65 seconds at 50 degrees Celsius, carry out 10 circulations;
Step S32: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extend 55-65 seconds, Carry out 24-28 circulation;
Step S33: annealing when temperature is 90-95 degrees Celsius time variation 18-22 seconds, 60-50 degrees Celsius and extend 55-65 seconds, Carry out 3 circulations.
5. detecting κ-casein genotype method based on KASP technology as claimed in claim 4, which is characterized in that the step In rapid S3, the step of PCR amplification, includes:
Step S31: it is moved back when temperature being 94 degrees Celsius hot activation 15 minutes, 94 degrees Celsius time variation 20 seconds, 61-55 degrees Celsius Fire and extension 60 seconds, carry out 10 circulations;
Step S32: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 55 degrees Celsius and extend 60 seconds, carries out 26 circulations;
Step S33: annealing when temperature is 94 degrees Celsius time variation 20 seconds, 57 degrees Celsius and extend 60 seconds, carries out 3 circulations.
6. detecting κ-casein genotype method based on KASP technology as described in claim 1, which is characterized in that the step In rapid S1, the extracting method of DNA sample includes:
Step S11: blood-material is pre-processed;
Step S12: blood-material is successively digested by Porteinase K solution and buffer GB, clarifies solution system;
Step S13: addition buffer solution B D mixes well;
Step S14: solution is placed in adsorption column CG2, and waste liquid is abandoned in room temperature centrifugation;
Step S15: being added buffer GDB, and waste liquid is abandoned in room temperature centrifugation;
Step S16: being added buffer PWB, and room temperature centrifugation is abandoned waste liquid, is repeated at least once more;
Step S17: the adsorption column CG2 finally obtained is placed in collecting pipe, and waste liquid is abandoned in room temperature centrifugation;
Step S18: elution adsorption column CG2 it is quantitative to carry out DNA;
Step S19: the integrality of DNA sample is detected by agarose gel electrophoresis.
7. detecting κ-casein genotype method based on KASP technology as claimed in claim 6, which is characterized in that the step In rapid S11, carrying out pretreated step to blood-material includes: that the cell cracking of 1-2.5 times of volume is added into blood sample Liquid CL, is handled using Syrup-homogenizing instrument, is centrifuged later, and supernatant is abandoned, and leaves nucleus precipitating, and into nucleus precipitating, addition is slow Fliud flushing GS, oscillation are mixed to thorough;
Wherein, if without blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:1, If there is blood clot in blood-material, the volume ratio of the buffer GS of the volume and addition of blood-material is 5:2.
8. detecting κ-casein genotype method based on KASP technology as claimed in claim 6, which is characterized in that the step In rapid S12, if blood-material, without clot, the volume ratio of Porteinase K solution and blood-material is 1:50, buffer GB Volume ratio with blood-material is 1:5;If blood-material has clot, the volume ratio of Porteinase K solution and blood-material For 1:25, the volume ratio of buffer GB and blood-material is 2:5.
9. detecting κ-casein genotype method based on KASP technology as claimed in claim 6, which is characterized in that
In the step S13, the volume ratio of added buffer GB is between 1:1- in added buffer solution B D and step S12 2:1;
In the step S15, the volume ratio of added buffer GB is between 2 in added buffer GDB and step S12: 1-3:1;
In the step S16, the volume ratio of added buffer GB is between 2 in added buffer PWB and step S12: 1-4:1;
Also, the step S14 is into step S16, the speed of centrifugation between 10000-14000rpm, centrifugation time between 20-40 seconds;
In the step S17, the speed of centrifugation is between 10000-14000rpm, and centrifugation time is between 1.5-2.5 points.
10. detecting κ-casein genotype method based on KASP technology as claimed in claim 6, which is characterized in that described In step S18, the elution process of adsorption column CG2 includes:
Step S18a: elution buffer TB, the volume that elution buffer TB is added, with step S12 is vacantly added dropwise to adsorption column CG2 In added buffer GB volume ratio between 1:4-1:1;
Step S18b: being placed at room temperature for two minutes, and waste liquid is abandoned in room temperature centrifugation, and centrifugal speed is between 10000-14000rpm, when centrifugation Between between 1.5-2.5 point.
CN201811181116.4A 2018-10-10 2018-10-10 κ-casein genotype method is detected based on KASP technology Pending CN109321639A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811181116.4A CN109321639A (en) 2018-10-10 2018-10-10 κ-casein genotype method is detected based on KASP technology

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811181116.4A CN109321639A (en) 2018-10-10 2018-10-10 κ-casein genotype method is detected based on KASP technology

Publications (1)

Publication Number Publication Date
CN109321639A true CN109321639A (en) 2019-02-12

Family

ID=65261255

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811181116.4A Pending CN109321639A (en) 2018-10-10 2018-10-10 κ-casein genotype method is detected based on KASP technology

Country Status (1)

Country Link
CN (1) CN109321639A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111057763A (en) * 2019-12-16 2020-04-24 人和未来生物科技(长沙)有限公司 Kit for detecting human breast cancer susceptibility genotyping and use method and application thereof
IT202100004640A1 (en) * 2021-03-01 2022-09-01 Univ Degli Studi Padova METHOD FOR PREDICTING THE DAIRY ATTITUDE INDEX AND GENE CHIP SUITABLE FOR CARRYING OUT THIS METHOD

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101970688A (en) * 2007-09-12 2011-02-09 美国辉瑞有限公司 Methods of using genetic markers and related epistatic interactions
CN105219839A (en) * 2014-06-18 2016-01-06 上海派森诺生物科技有限公司 A kind of method detecting beta-casein gene type based on enzyme cutting method
CN107058582A (en) * 2017-06-06 2017-08-18 北京奶牛中心 The method that β casein genotypes are detected based on KASP
RU2646140C1 (en) * 2017-03-24 2018-03-01 Общество с ограниченной ответственностью "АгроВет" Set of primers sequence and allele-specific probes for simultaneous four mutant kappa-casein alleles gene diagnostics in bovine cattle

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101970688A (en) * 2007-09-12 2011-02-09 美国辉瑞有限公司 Methods of using genetic markers and related epistatic interactions
CN105219839A (en) * 2014-06-18 2016-01-06 上海派森诺生物科技有限公司 A kind of method detecting beta-casein gene type based on enzyme cutting method
RU2646140C1 (en) * 2017-03-24 2018-03-01 Общество с ограниченной ответственностью "АгроВет" Set of primers sequence and allele-specific probes for simultaneous four mutant kappa-casein alleles gene diagnostics in bovine cattle
CN107058582A (en) * 2017-06-06 2017-08-18 北京奶牛中心 The method that β casein genotypes are detected based on KASP

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
J. KYSE ĽOVÁ等: "Simultaneous identifi cation of CSN3 and LGB genotypes in cattle by high-resolution melting curve analysis", 《LIVESTOCK SCIENCE》 *
LGC公司: "KASP genotyping chemistry User guide and manual", 《LGC公司》 *
PETER HRISTOV等: "《Milk Production – Advanced Genetic Traits, Cellular Mechanism, Animal Management and Health》", 31 December 2012, INTECHOPEN *
TIANGEN: "TIANamp Blood DNA Kit血液基因组DNA提取试剂盒", 《原创力文档》 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111057763A (en) * 2019-12-16 2020-04-24 人和未来生物科技(长沙)有限公司 Kit for detecting human breast cancer susceptibility genotyping and use method and application thereof
CN111057763B (en) * 2019-12-16 2023-09-26 人和未来生物科技(长沙)有限公司 Kit for detecting susceptibility genotyping of human breast cancer, and use method and application thereof
IT202100004640A1 (en) * 2021-03-01 2022-09-01 Univ Degli Studi Padova METHOD FOR PREDICTING THE DAIRY ATTITUDE INDEX AND GENE CHIP SUITABLE FOR CARRYING OUT THIS METHOD
WO2022185181A1 (en) * 2021-03-01 2022-09-09 Università Degli Studi Di Padova Method for predicting the milk clotting ability index and gene chip adapted to carry out this method.

Similar Documents

Publication Publication Date Title
CN107604078B (en) Molecular marker related to sheep wool fiber diameter character and specific primer pair and application thereof
CN103205503B (en) Method for detecting CLCN1 gene mutation, kit and specific primer
CN104745679A (en) Method and kit for non-invasive detection of EGFR (epidermal growth factor receptor) gene mutation
CN112662788B (en) SNP marker related to milk production traits of Holstein cows in south China and application thereof
CN109321639A (en) κ-casein genotype method is detected based on KASP technology
CN109112217A (en) A kind of and pig body length and the significantly associated genetic marker of number of nipples and application
CN101875971A (en) Rapid detection of BRAF (Block-Repeated Active Flag) gene mutation
CN111690759A (en) Specific primer, kit and method for detecting RPA of citrus canker pathogen
CN116479145A (en) Multiplex fluorescence quantitative PCR primer probe set, method and kit for simultaneously detecting three bifidobacteria
CN108624686B (en) A kind of probe library, detection method and the kit of detection BRCA1/2 mutation
CN101245393B (en) Method and reagent kit for forecasting outbreak age of carcinoma of colon
CN114292938A (en) SSR fingerprint identification method and construction method of stropharia rugoso-annulata strain
CN109402265A (en) Method based on KASP technology detection beta lactoglobulin genotype
CN113462783A (en) Brain glioma chromosome lp/19q detection method based on MassArray nucleic acid mass spectrum and application thereof
KR102147340B1 (en) A composition for detecting Ganoderma microorganism and diagnosing basal stem rot and a method using the same
CN108486274B (en) Molecular marker related to content of feruloyl arabinoxylan in wheat grains
Cravero et al. Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantity
CN114480615B (en) Primer group and kit for detecting HLA-B5101 alleles
CN108660223B (en) Siberian sturgeon and identification method of Siberian sturgeon
CN108531620B (en) Primer and method for identifying acipenser schrencki, acipenser sibiricus and filial generation thereof
KR102147351B1 (en) A composition for detecting Ganoderma microorganism and diagnosing basal stem rot and a method using the same
CN116814841B (en) Primer group for identifying rice black brown glume gene HK4, and method and application thereof
CN110760578B (en) Kit for detecting polymorphism of human CYP2C9 and VKORC1 genes
KR102147412B1 (en) A composition for detecting Ganoderma microorganism and diagnosing basal stem rot and a method using the same
KR102412793B1 (en) SNP genetic markers and primer sets for discriminating domestic wheat cultivar and uses thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20190212

RJ01 Rejection of invention patent application after publication